USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensébeautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
Phone801-954-7100
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.19 billion
Profitability
Miscellaneous
Employees1,911
Next Earnings Date4/23/2019 (Estimated)
OptionableOptionable
USANA Health Sciences (NYSE:USNA) Frequently Asked Questions
What is USANA Health Sciences' stock symbol?
USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."
How will USANA Health Sciences' stock buyback program work?
USANA Health Sciences announced that its Board of Directors has approved a stock repurchase plan on Tuesday, October 23rd 2018, which authorizes the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 5.9% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's leadership believes its stock is undervalued.
How were USANA Health Sciences' earnings last quarter?
USANA Health Sciences, Inc. (NYSE:USNA) announced its quarterly earnings data on Tuesday, February, 5th. The company reported $1.32 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.33 by $0.01. The company earned $299.02 million during the quarter, compared to analysts' expectations of $305.79 million. USANA Health Sciences had a net margin of 10.61% and a return on equity of 30.49%. The business's revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.11 earnings per share. View USANA Health Sciences' Earnings History.
When is USANA Health Sciences' next earnings date?
What guidance has USANA Health Sciences issued on next quarter's earnings?
USANA Health Sciences issued an update on its FY19 earnings guidance on Tuesday, February, 5th. The company provided earnings per share (EPS) guidance of $5.25-5.55 for the period, compared to the Thomson Reuters consensus estimate of $5.86. The company issued revenue guidance of $1.25-1.30 billion, compared to the consensus revenue estimate of $1.31 billion.
What price target have analysts set for USNA?
2 equities research analysts have issued 12-month price targets for USANA Health Sciences' stock. Their forecasts range from $135.00 to $135.00. On average, they expect USANA Health Sciences' stock price to reach $135.00 in the next twelve months. This suggests a possible upside of 56.6% from the stock's current price. View Analyst Price Targets for USANA Health Sciences.
What is the consensus analysts' recommendation for USANA Health Sciences?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for USANA Health Sciences.
Has USANA Health Sciences been receiving favorable news coverage?
Media stories about USNA stock have been trending neutral recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. USANA Health Sciences earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an impact on the company's share price in the next several days.
Who are some of USANA Health Sciences' key competitors?
Some companies that are related to USANA Health Sciences include Tilray (TLRY), STADA Arzneimittel (STDAF), Cronos Group (CRON), CV Sciences (CVSI), Canopy Rivers (RIV), Chromadex (CDXC), Foamix Pharmaceuticals (FOMX), Mediwound (MDWD), Natural Alternatives International (NAII), China Jo-Jo Drugstores (CJJD), Mannatech (MTEX), Cyanotech (CYAN), GLG Life Tech (GLGLF), Tauriga Sciences (TAUG) and FitLife Brands (FTLF).
What other stocks do shareholders of USANA Health Sciences own?
Who are USANA Health Sciences' key executives?
USANA Health Sciences' management team includes the folowing people:
- Dr. Myron W. Wentz, Founder & Chairman (Age 78)
- Mr. Kevin G. Guest, CEO & Director (Age 56)
- Mr. Jim Brown, Pres & COO (Age 50)
- Mr. G. Douglas Hekking, Chief Financial Officer (Age 49)
- Mr. Daniel A. Macuga Jr., Chief Communications & Marketing Officer (Age 49)
Who are USANA Health Sciences' major shareholders?
USANA Health Sciences' stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (4.54%), Acadian Asset Management LLC (3.58%), Dimensional Fund Advisors LP (2.62%), Norges Bank (1.26%), Prudential Financial Inc. (1.04%) and Robeco Institutional Asset Management B.V. (0.99%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.
Which major investors are selling USANA Health Sciences stock?
USNA stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Fort L.P., Millennium Management LLC, Two Sigma Investments LP, Prudential Financial Inc., Bank of New York Mellon Corp, Acadian Asset Management LLC and Mackay Shields LLC. Company insiders that have sold USANA Health Sciences company stock in the last year include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert A Sinnott and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.
Which major investors are buying USANA Health Sciences stock?
USNA stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, MERIAN GLOBAL INVESTORS UK Ltd, Nordea Investment Management AB, First Trust Advisors LP, APG Asset Management N.V., Burney Co., Bank of America Corp DE and BlackRock Inc.. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull and Myron W Wentz. View Insider Buying and Selling for USANA Health Sciences.
How do I buy shares of USANA Health Sciences?
Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is USANA Health Sciences' stock price today?
One share of USNA stock can currently be purchased for approximately $86.20.
How big of a company is USANA Health Sciences?
USANA Health Sciences has a market capitalization of $2.01 billion and generates $1.19 billion in revenue each year. The company earns $126.22 million in net income (profit) each year or $5.16 on an earnings per share basis. USANA Health Sciences employs 1,911 workers across the globe.
What is USANA Health Sciences' official website?
How can I contact USANA Health Sciences?
USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]
MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
